Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumors.
Steinbügl M, Nemes K, Johann P, Kröncke T, Tüchert S, da Costa MJG, Ebinger M, Schüller U, Sehested A, Hauser P, Reinhard H, Sumerauer D, Hettmer S, Jakob M, Hasselblatt M, Siebert R, Witt O, Gerss J, Kerl K, Frühwald MC.
Steinbügl M, et al. Among authors: fruhwald mc.
Pediatr Blood Cancer. 2021 Dec;68(12):e29267. doi: 10.1002/pbc.29267. Epub 2021 Aug 4.
Pediatr Blood Cancer. 2021.
PMID: 34347371